Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 871-881

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 934-0874, Iss. 11, 2015-11 ,pp. : 1345-1349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV‐decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 11, 2015-11 ,pp. : 1345-1349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early Relapse of Unresectable Gallbladder Cancer after Discontinuation of Gemcitabine Monotherapy Administered for 5 Years in a Patient Who Had Complete Response to the Treatment

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-10 ,pp. : 531-537

Karger

Access to resources Recommend Favorite

O‐27: Early HCV RNA kinetics predict relapse to sofosbuvir/ribavirin dual therapy

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 16-16

John Wiley & Sons Inc

Access to resources Recommend Favorite